Incidence of Post-ERCP Pancreatitis in Patients Receiving Rectal Indomethacin vs. Compounded Rectal Diclofenac Prophylaxis-Reference-Cited by-同舟云学术

Incidence of Post-ERCP Pancreatitis in Patients Receiving Rectal Indomethacin vs. Compounded Rectal Diclofenac Prophylaxis

Published:2024-08-31 Issue: Volume: Page:
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Janssens Laurens P.,Yamparala Aishwarya,Martin John,O’Meara John,Harmsen William S.,Sathi Thanmay,Lemke Elizabeth,Abu Dayyeh Barham K.,Bofill-Garcia Aliana,Petersen Bret T.,Storm Andrew C.,Topazian Mark,Vargas Eric J.,Chandrasekhara Vinay,Law Ryan J.

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10620-024-08604-5.pdf

Reference38 articles.

1. Kochar B, Akshintala VS, Afghani E et al. Incidence, severity, and mortality of post-ERCP pancreatitis: a systematic review by using randomized, controlled trials. Gastrointest Endosc. 2015;81:143-149.e9. https://doi.org/10.1016/j.gie.2014.06.045.

2. Elmunzer BJ, Scheiman JM, Lehman GA et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med. 2012;366:1414. https://doi.org/10.1056/NEJMOA1111103.

3. Buxbaum JL, Freeman M, Amateau SK et al. American Society for Gastrointestinal Endoscopy guideline on post-ERCP pancreatitis prevention strategies: summary and recommendations. Gastrointest Endosc. 2023;97:153–162. https://doi.org/10.1016/j.gie.2022.10.005.

4. Dumonceau J-M, Kapral C, Aabakken L et al. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2019;52:127–149. https://doi.org/10.1055/a-1075-4080.

5. Kubiliun NM, Adams MA, Akshintala VS et al. Evaluation of pharmacologic prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: a systematic review. Clin Gastroenterol Hepatol. 2015;13:1231–1239. https://doi.org/10.1016/j.cgh.2014.11.038.